Polypharmacy among pediatric cancer patients dying in the hospital

CONCLUSIONS: Polypharmacy is ubiquitous among pediatric oncology patients at EOL. Disease type and DNR status may affect medication burden and deprescribing during the last hospitalization.PMID:34251125

Source: The Israel Medical Association Journal - July 12, 2021 Category: General Medicine Authors: Sharon Tamir Daniel Kurnik Myriam Weyl Ben-Arush Sergey Postovsky Source Type: research